Tanaka K, Hayashi R, Ariyama Y, Takahashi N, Namba F. Management of bronchopulmonary dysplasia in Japan: A nationwide survey. Early Hum Dev. 2023 Nov;186:105867. doi: 10.1016/j.earlhumdev.2023.105867. Epub 2023 Sep 26. PMID: 37788509.
Saito K, Nishimura E, Ota E, Namba F, Swa T, Ramson J, Lavin T, Cao J, Vogel JP. Antenatal corticosteroids in specific groups at risk of preterm birth: a systematic review. BMJ Open. 2023 Sep 22;13(9):e065070. doi: 10.1136/bmjopen-2022-065070. PMID: 37739474; PMCID: PMC10533784.
Kobayashi A, Ito M, Ota E, Namba F. School-Age Outcomes of Antenatal Magnesium Sulphate in Preterm Infants. Children (Basel). 2023 Jul 31;10(8):1324. doi: 10.3390/children10081324. PMID: 37628323; PMCID: PMC10453514.
Sudo Y, Seki-Nagasawa J, Kajikawa D, Kuratsuji G, Haga M, Shokraneh F, Yamaji N, Ota E, Namba F. Effect of Fentanyl for Preterm Infants on Mechanical Ventilation: A Systematic Review and Meta-Analysis. Neonatology. 2023;120(3):287-294. doi: 10.1159/000529440. Epub 2023 Mar 29. PMID: 36990067.
Yamaji N, Suzuki H, Saito K, Swa T, Namba F, Vogel JP, Ramson JA, Cao J, Tina L, Ota E. Tocolytic Therapy Inhibiting Preterm Birth in High-Risk Populations: A Systematic Review and Meta-Analysis. Children (Basel). 2023 Feb 24;10(3):443. doi: 10.3390/children10030443. PMID: 36980001; PMCID: PMC10047044.
Ito M, Kato S, Saito M, Miyahara N, Arai H, Namba F, Ota E, Nakanishi H. Bronchopulmonary Dysplasia in Extremely Premature Infants: A Scoping Review for Identifying Risk Factors. Biomedicines. 2023 Feb 14;11(2):553. doi: 10.3390/biomedicines11020553. PMID: 36831089; PMCID: PMC9953397.
Maeda R, Fujita D, Tanaka K, Ozawa J, Haga M, Miyahara N, Namba F, Kobashi S. Predicting the development of chronic lung disease in neonates from chest X-ray images using deep learning. 2023 IEEE 53rd International Symposium on Multiple-Valued Logic (ISMVL). 2023;48-53. doi: 10.1109/ISMVL57333.2023.00020.